相关实验视频

Updated: Sep 18, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

侵袭性冠状动脉功能测试在患者之前的PCI谁有持续的ANOCA

Vedant S Pargaonkar¹, Christopher C Y Wong¹, Yasuhiro Honda¹

¹Division of Cardiovascular Medicine, Department of Medicine, Stanford School of Medicine, CA.

Circulation. Cardiovascular interventions

|June 25, 2025

概括

综合冠状动脉功能测试 (CFT) 有助于确定皮肤冠状动脉干预 (PCI) 后持续性心痛的原因. 许多患者表现出内皮功能障碍,或心肌桥梁,通过向治疗得到改善.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
诊断成像诊断成像诊断成像

背景情况:

经皮肤冠状动脉干预 (PCI) 后心痛的管理具有挑战性.
综合冠状动脉功能测试 (CFT) 可以检测心痛和非阻塞性冠状动脉患者的隐性冠状动脉异常.
在PCI后患有持续性心痛和没有阻塞性冠状动脉疾病的患者中,CFT的实用性仍未被探索.

研究的目的:

评估综合冠状动脉功能测试 (CFT) 在经皮冠状动脉干预 (PCI) 后患有持续性心痛的患者的诊断产量和治疗影响,尽管非阻塞性冠状动脉疾病.
在这个患者群体中评估各种冠状动脉异常的患病率,包括内皮功能障碍,表心和微血管,低分流储备,冠状动脉微血管功能障碍和心肌桥梁.
确定CFT指导管理对症状严重程度和生活质量的影响.

主要方法:

一组46名先前患有PCI和持续性胸痛的患者接受了综合冠状动脉功能测试 (CFT).
CFT包括对内皮功能障碍,表心和微血管,分数流量储备 (FFR),冠状动脉微血管功能障碍和使用血管内超声波的心肌桥梁的评估.
症状严重程度和生活质量被测量使用西雅图Angina问卷在CFT前和1年后.

主要成果:

该研究包括46名患者 (63%为女性,平均年龄为60岁) 患有严重的胸痛症状和生活质量差.
CFT显示FFR的中位数为0.84,其中19.6%的FFR≤0.8.8. 内皮功能障碍发生在36.9%,上心发生在56.5%,微血管发生在17.4%,冠状动脉微血管功能障碍发生在43.5%,心肌桥梁发生在63%的人群中.
患者报告说,在CFT后1年的西雅图Angina问卷得分显著改善,表明更好的症状控制和生活质量.

结论:

患有PCI后持续性 angina 的患者往往有显著的潜在冠状动脉异常,包括内皮功能障碍,和心肌桥梁.
综合性CFT对于在这些具有挑战性的患者中诊断持续性 angina 的原因是有价值的.
以CFT为指导的治疗可以改善PCI后心脏病患者的症状和生活质量.

关键词:

胸痛是一种心痛.人类人类人类人类人类人类.心肌架构桥梁是什么意思通过皮肤进行冠状动脉干预.人们的生活质量.

更多相关视频

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

相关概念视频

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...